Asia Pacific autoimmune disease diagnostics market will grow by 9.7% annually with a total addressable market cap of $19.06 billion over 2022-2031, this sector presents promising opportunities for ...

The Asia Pacific minimal residual disease (MRD) testing market is poised for remarkable growth, with projections indicating a robust 15.5% annual increase. Over the forecast period spanning from 2022 ...

Liver disease remains a silent threat. “The liver can withstand injury for years without producing symptoms,” said Dr ...

To this end, the WHO, UNICEF and UNAIDS have launched the Regional Roadmap for the Triple Elimination of Mother-to-Child ...

In the near future, the Minimal Residual Disease (MRD) testing industry is poised to experience remarkable growth and ...

OHE’s BRAVER Roadmap outlines how adopting a societal perspective in HTA can improve equity, innovation, and health outcomes in the Asia-Pacific region.

The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' ...

With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to ...

The Asia-Pacific Business Forum (APBF) 2025 opened today in Kuala Lumpur with a strong call for the private sector to lead ...

At the prestigious 2025 Healthcare Asia Awards held in Kuala Lumpur, China Medical University Hospital (CMUH) emerged as a ...

Published today by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the report highlights ...